To our knowledge, since the publication of the meta-analysis there have been no reports examining the CD8:Foxp3+ T-cell ratio in the setting of renal cell carcinoma, and differences in T-cell content in primary versus metastatic specimens are unknown. Here, CD8A is linked to renal cell carcinoma.